Dr. Reddy’s Laboratories introduces Toripalimab in India for nasopharyngeal carcinoma

The immuno-oncology drug is approved by global regulatory authorities for the treatment of nasopharyngeal carcinoma. Credit: National Cancer Institute on Unsplash.